Universal flu jab passes crucial test

Scientists at Oxford University have successfully tested a universal flu vaccine that could work against all known strains of the illness, taking a significant step in the fight against a disease that affects billions each year.

The treatment — using a new technique and tested for the first time on humans infected with flu — targets a different part of the flu virus to traditional vaccines, meaning it does not need to be expensively reformulated every year to match the most prevalent virus that is circulating the world.

Developed by a team led by Dr Sarah Gilbert at Oxford’s Jenner Institute, the vaccine targets proteins inside the flu virus that are common across all strains instead of those that sit on the virus’s external coat that are liable to mutate.

If used widely, a universal flu vaccine could prevent pandemics, such as the swine flu outbreaks of recent years, and end the need for a seasonal flu jab. “The problem with flu is that you’ve got lots of different strains and they keep changing,” said Adrian Hill, the director of the Jenner Institute.

“Occasionally, one comes out of wildfowl or pigs and we’re not immune. We need new vaccines and we can’t make them fast enough.”


In the UK the government spent an estimated £1,2-billion in preparing for the swine flu outbreak of last winter. The process of developing a seasonal vaccine takes at least four months and if the flu strain is highly pathogenic — as in 1918 when millions of people died — the delay means more people get sick and die before the vaccine is ready.

In her trial Gilbert vaccinated 11 healthy volunteers and then infected them, with 11 non-vaccinated volunteers, with the Wisconsin strain of the H3N2 influenza A virus, which was first isolated in 2005.

She monitored the volunteers’ symptoms twice a day, including runny noses, coughs and sore throats, and she calculated how much mucus everyone produced by weighing the tissues they used.

The next step for the vaccine is to stage a field trial in which several thousands are given the vaccine and their outcomes are compared with several thousands who do not get it.

It will take several more years, therefore, before Gilbert’s vaccine can be licensed for use alongside traditional antibody-inducing vaccines. — Guardian News & Media 2011

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Alok Jha
Alok Jha works from London, England. Science correspondent at @TheEconomist Former @WellcomeTrust fellow Author: The Water Book https://t.co/lySv8Xl9zt [email protected] Alok Jha has over 31762 followers on Twitter.

Related stories

Advertising

Subscribers only

Mahikeng compounds its mess

The ailing town that wasted R2-billion appoints a municipal manager rated ‘basic’, the lowest level

No mercy for teachers who are found guilty of misconduct

New regulations give direction on what sanctions should be imposed on disgraceful teachers, including lifetime bans for serious offences

More top stories

Resuscitate the public broadcaster

The SABC is simply too important to South Africa’s democracy for it to be gutted: we cannot allow it to die

Climate change threatens survival of endemic species the most

If Earth warms by 3°C, a third of species living on land and about half of endemic marine species will become extinct

Anger as Ace alters step-aside rules

Outraged provincial secretaries called for a meeting with Luthuli House after the ANC secretary general broadened the NEC’s step-aside resolution

Food delivery drivers seek better employee rights

A group of South African Uber drivers plan to go to court to seek employee rights including compensation for overtime and holiday pay, hoping for a similar victory to that of British drivers in March
Advertising

press releases

Loading latest Press Releases…